Yang ZeSong, Wang Fang, Lin Deng, Li Qiuyan, Hong Yun, Hu Minxiong, Zhang Dahong, Ye Liefu
Shengli Clinical Medical College of Fujian Medical University, Department of Urology, Fujian Provincial Hospital, Fuzhou, China.
Department of Clinical Medicine, Fujian Health College, Fuzhou, China.
Front Surg. 2022 Jun 8;9:901033. doi: 10.3389/fsurg.2022.901033. eCollection 2022.
The aim of this study is to evaluate a potential successful strategy for treating large renal hilar angiomyolipoma (RHAML) during the procedure of laparoscopic nephron-sparing surgery (NSS).
The total study population includes 12 patients with large RHAMLs who underwent laparoscopic NSS in the Department of Urology of Fujian Provincial hospital and People's Hospital of Zhejiang, ranging from January 2016 to March 2020. The perioperative variables, intraoperative procedures, and postprocedure complications were all recorded. Three months later, all patients returned to the hospital to check their postoperative recovery by reviewing the computed tomography urography (CTU) image. In the follow-up, patients were asked to have their review by CT or color doppler ultrasound every year.
Laparoscopic NSS was successfully performed in all patients. The average operation time was 113.33 ± 33.39 min; the intraoperative blood loss was about 137.50 ± 91.17 ml; the warm ischemia time was 25.25 ± 4.88 min; the drainage tube extubation time was 4.58 ± 2.07 days; and the hospital stay time was 6.42 ± 1.78 days. The average follow-up time was 14.58 ± 9.18 months. After 3 months, all CTU images showed an unobstructed urinary tract in the patient, and no tumor recurrence was found. In addition, no patients had renal atrophy and urine extravasation during follow-up.
Laparoscopic NSS for RHAML is complex and technically demanding, but good surgical design and operation can achieve satisfactory surgical results. Modified laparoscopic NSS was a beneficial technique and may provide a reference for treating patients with RHAML.
本研究旨在评估在腹腔镜保留肾单位手术(NSS)过程中治疗大型肾门血管平滑肌脂肪瘤(RHAML)的一种潜在成功策略。
研究总人群包括12例大型RHAML患者,于2016年1月至2020年3月期间在福建省立医院泌尿外科和浙江省人民医院接受了腹腔镜NSS。记录围手术期变量、术中操作及术后并发症。3个月后,所有患者返回医院,通过复查计算机断层扫描尿路造影(CTU)图像检查术后恢复情况。在随访中,要求患者每年进行CT或彩色多普勒超声复查。
所有患者均成功实施了腹腔镜NSS。平均手术时间为113.33±33.39分钟;术中出血量约为137.50±91.17毫升;热缺血时间为25.25±4.88分钟;引流管拔除时间为4.58±2.07天;住院时间为6.42±1.78天。平均随访时间为14.58±9.18个月。3个月后,所有CTU图像显示患者尿路通畅,未发现肿瘤复发。此外,随访期间无患者出现肾萎缩和尿外渗。
腹腔镜NSS治疗RHAML复杂且技术要求高,但良好的手术设计和操作可取得满意的手术效果。改良腹腔镜NSS是一种有益的技术,可为治疗RHAML患者提供参考。